These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 19552558

  • 21. Comparison of traditional and novel tableting excipients: physical and compaction properties.
    Hentzschel CM, Sakmann A, Leopold CS.
    Pharm Dev Technol; 2012; 17(6):649-53. PubMed ID: 21740091
    [Abstract] [Full Text] [Related]

  • 22. Relationships between response surfaces for tablet characteristics of placebo and API-containing tablets manufactured by direct compression method.
    Hayashi Y, Tsuji T, Shirotori K, Oishi T, Kosugi A, Kumada S, Hirai D, Takayama K, Onuki Y.
    Int J Pharm; 2017 Oct 30; 532(1):82-89. PubMed ID: 28859939
    [Abstract] [Full Text] [Related]

  • 23. A qualitative method for monitoring of nucleation and granule growth in fluid bed wet granulation by reflectance near-infrared spectroscopy.
    Li W, Cunningham J, Rasmussen H, Winstead D.
    J Pharm Sci; 2007 Dec 30; 96(12):3470-7. PubMed ID: 17549771
    [Abstract] [Full Text] [Related]

  • 24. Lignin and Cellulose Blends as Pharmaceutical Excipient for Tablet Manufacturing via Direct Compression.
    Domínguez-Robles J, Stewart SA, Rendl A, González Z, Donnelly RF, Larrañeta E.
    Biomolecules; 2019 Aug 28; 9(9):. PubMed ID: 31466387
    [Abstract] [Full Text] [Related]

  • 25. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J, Crean B, Davies M, Toon R, Jinks P, Roberts CJ.
    Int J Pharm; 2008 Sep 01; 361(1-2):209-21. PubMed ID: 18577435
    [Abstract] [Full Text] [Related]

  • 26. Effects of various excipients on tizanidine hydrochloride tablets prepared by direct compression.
    Khan LG, Razvi N, Anjum F, Siddiqui SA, Ghayas S.
    Pak J Pharm Sci; 2014 Sep 01; 27(5):1249-54. PubMed ID: 25176379
    [Abstract] [Full Text] [Related]

  • 27. Microcrystalline cellulose, a direct compression binder in a quality by design environment--a review.
    Thoorens G, Krier F, Leclercq B, Carlin B, Evrard B.
    Int J Pharm; 2014 Oct 01; 473(1-2):64-72. PubMed ID: 24993785
    [Abstract] [Full Text] [Related]

  • 28. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes.
    Kushner J, Langdon BA, Hicks I, Song D, Li F, Kathiria L, Kane A, Ranade G, Agarwal K.
    J Pharm Sci; 2014 Feb 01; 103(2):527-38. PubMed ID: 24375069
    [Abstract] [Full Text] [Related]

  • 29. Rapid formulation screening with a Multipart Microscale Fluid bed Powder processor.
    Kivikero N, Murtomaa M, Antikainen O, Hatara J, Juppo AM, Sandler N.
    Pharm Dev Technol; 2011 Aug 01; 16(4):358-66. PubMed ID: 20387990
    [Abstract] [Full Text] [Related]

  • 30. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression.
    Sun WJ, Aburub A, Sun CC.
    J Pharm Sci; 2017 Jul 01; 106(7):1772-1777. PubMed ID: 28322940
    [Abstract] [Full Text] [Related]

  • 31. Development of immediate release Rupatadine fumarate 10 mg tablets: A Quality by Design (QbD) approach.
    Castillo Henríquez L, Vargas Zúñiga R, Carazo Berrocal G, Madrigal Redondo G, Calvo Guzmán B, Baltodano Viales E.
    Drug Dev Ind Pharm; 2019 Oct 01; 45(10):1674-1681. PubMed ID: 31378098
    [Abstract] [Full Text] [Related]

  • 32. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process.
    Karande AD, Heng PW, Liew CV.
    Int J Pharm; 2010 Aug 30; 396(1-2):63-74. PubMed ID: 20558264
    [Abstract] [Full Text] [Related]

  • 33. Improving the content uniformity of a low-dose tablet formulation through roller compaction optimization.
    am Ende MT, Moses SK, Carella AJ, Gadkari RA, Graul TW, Otano AL, Timpano RJ.
    Pharm Dev Technol; 2007 Aug 30; 12(4):391-404. PubMed ID: 17763144
    [Abstract] [Full Text] [Related]

  • 34. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
    Alyami H, Dahmash E, Bowen J, Mohammed AR.
    PLoS One; 2017 Aug 30; 12(6):e0178772. PubMed ID: 28609454
    [Abstract] [Full Text] [Related]

  • 35. Examining mechanical properties of various pharmaceutical excipients with the gravitation-based high-velocity compaction analysis method.
    Tanner T, Antikainen O, Ehlers H, Blanco D, Yliruusi J.
    Int J Pharm; 2018 Mar 25; 539(1-2):131-138. PubMed ID: 29414122
    [Abstract] [Full Text] [Related]

  • 36. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY, Lin KH, Li MJ.
    J Pharm Sci; 2002 Sep 25; 91(9):2040-6. PubMed ID: 12210050
    [Abstract] [Full Text] [Related]

  • 37. Influence of the porosity of cushioning excipients on the compaction of coated multi-particulates.
    Elsergany RN, Chan LW, Heng PWS.
    Eur J Pharm Biopharm; 2020 Jul 25; 152():218-228. PubMed ID: 32445966
    [Abstract] [Full Text] [Related]

  • 38. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
    Hancock BC, Garcia-Munoz S.
    J Pharm Sci; 2013 Mar 25; 102(3):982-6. PubMed ID: 23280670
    [Abstract] [Full Text] [Related]

  • 39. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets.
    Patel H, Stalcup A, Dansereau R, Sakr A.
    Int J Pharm; 2003 Oct 02; 264(1-2):35-43. PubMed ID: 12972334
    [Abstract] [Full Text] [Related]

  • 40. [Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances].
    Marczyiński Z.
    Polim Med; 2009 Oct 02; 39(4):51-60. PubMed ID: 20099736
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.